Tower Research Capital LLC (Trc) Amicus Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 58,075 shares of FOLD stock, worth $521,513. This represents 0.01% of its overall portfolio holdings.
Number of Shares
58,075
Previous 11,189
419.04%
Holding current value
$521,513
Previous $119,000
359.66%
% of portfolio
0.01%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
311MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$263 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA28.5MShares$256 Million0.05% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$219 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$218 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$208 Million3.18% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.52B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...